Key Stats for Accenture Stock
- Current Price: $176.89
- Target Price (Mid): ~$257
- Street Target: ~$179
- Potential Total Return: ~45%
- Annualized IRR: ~10% / year
Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free) >>>
What Happened?
Accenture (ACN) spent the first half of 2026 as one of the most punished names in large-cap tech, and then it stopped falling. The stock hit its 52-week low of $118.15 on June 22, capping a drawdown that TIKR pegs at 56.87% from the peak, and it has since staged a hard recovery, up about 29% in the past month alone to close at $176.89 on August 14. Part of that was a rebound off an oversold low, but the bigger driver was a run of AI and banking wins that reminded investors that the business underneath the falling chart never actually broke. The discomfort now belongs to anyone watching from the sidelines: the cheap price is gone, and the Street’s average target sits almost exactly where the shares already trade.
Buying a stock that has just run this hard means paying up for a recovery the market has started to believe. The useful work is figuring out what today’s price already assumes and whether the company’s own data still leaves room to be paid.
The Deals That Turned Sentiment
The catalyst that flipped the tape was a cluster of AI and banking wins that landed after Accenture’s June quarter. In late July, UniCredit announced a long-term collaboration with Accenture and IBM to redesign the bank’s technology across thirteen European markets, with Accenture acquiring IBM’s majority stake in the joint venture that runs much of UniCredit’s core infrastructure. That deal is announced and subject to regulatory approval, not yet closed. Days earlier, Accenture and Radisson Hotel Group launched a hotel-discovery app inside ChatGPT, extending the company’s OpenAI partnership into live agentic commerce.
These wins matter because they answer the exact bear case that crushed the stock: the fear that AI would disintermediate consultants rather than employ them. Chair and CEO Julie Sweet framed the through-line on the Q3 call: “The major theme of all of these programs is that we are moving clients from using AI to running on AI.” That is the difference between a pilot and a production contract, and it is where Accenture’s scale earns its keep. The rally also has fundamentals behind it. The same Q3 report that triggered June’s selloff, when management narrowed full-year local-currency growth to 3% to 4% on a roughly $100 million Middle East revenue hit, still showed revenue up about 6% to $18.72 billion, operating margin holding at 17%, adjusted earnings per share up 9% to $3.80, and free cash flow of $3.6 billion. The scare was about demand timing, not a broken business, which is why the stock could reprice upward so fast once the fear eased. Management also lifted its buyback authorization to $7.5 billion for fiscal 2026.
See historical and forward estimates for Accenture stock (It’s free!) >>>
The Multiple Is Cheap, But It Is No Longer a Gift
Accenture trades at about 12.3 times next-twelve-month earnings and roughly 14 times trailing earnings, below the 20-times-plus levels TIKR data shows the stock still carried as recently as late 2025. Against its peers, the discount is narrower than it looks. That 12.3x forward P/E sits under IBM at 18.3x and Infosys at 15.1x, but above Cognizant at 9.7x and Capgemini at 8.2x. The premium to those two is defensible given Accenture’s scale and margin profile, but it is a premium, not a bargain, relative to the whole group.
The mean analyst target has collapsed from around $323 a year ago to $179 today, essentially level with the share price, though that mean masks a wide range: the high target is $275, while Deutsche Bank sits at $136, and Wells Fargo trimmed to $194. Coverage has drifted toward the fence, with 11 buys and 3 outperforms against 13 holds and no sells. The market has stopped pricing Accenture for growth and started pricing it for maturity. Whether that is too cautious is a question the model can answer more directly than the tape.
See how Accenture performs against its peers in TIKR (It’s free!) >>>
TIKR Advanced Model Analysis
- Current Price: $176.89
- Target Price (Mid): ~$257
- Potential Total Return: ~45%
- Annualized IRR: ~10% / year
See analysts’ growth forecasts and price targets for Accenture stock (It’s free!) >>>
The two revenue drivers are modest and verifiable: low-single-digit organic growth in local currency, plus close to 2% of inorganic contribution as the roughly $9 billion in fiscal 2026 acquisitions layer in through fiscal 2027. The margin driver is continued operating-margin expansion, which reached 17% in the June quarter, up 20 basis points year over year, even while absorbing the Middle East hit. The primary risk is demand timing: if discretionary spend stays soft and managed-services deals keep slipping into later years, the revenue base that carries this return arrives late.
The case for buying here is that even conservative assumptions, roughly 4% revenue growth and margins pushing toward 12% net, produce a double-digit annualized return from a business generating billions in free cash flow and buying back stock. The case against is timing: the mid case realizes over four years, so a buyer at $177 is signing up to wait, and a rerating that never comes turns 10% a year into the dividend and the buyback alone.
Conclusion
The next real test is the Q4 fiscal 2026 report, expected in late September, which closes the books on the year management guided down in June. Watch two numbers. Federal revenue was guided to return to growth this quarter after a year of drag, and local-currency revenue was guided to a wide 1% to 5% range. A print near the top with Federal back in the black would confirm the recovery the stock has already partly priced. A print near the bottom, with the Middle East softness spreading further into discretionary spend, would tell buyers at $177 that they paid up too early. The chart has turned. The September report decides whether the business has.
See what stocks billionaire investors are buying so you can follow the smart money with TIKR.
Should You Invest in Accenture?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up Accenture, and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track Accenture alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Analyze Accenture on TIKR Free →
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
